Vector Laboratories
1976
FOUNDED
M&A
STATUS
Debt
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Developer and manufacturer of labeling and detection reagents. The company specializes in developing labeling and detection reagents which are critical components in immunohistochemistry studies and other life science research applications, enabling researchers at leading hospitals, academic research institutions and life science companies to receive new formulations of curing antifade mounting media for immunofluorescence applications that overcome many of the issues experienced with other setting antifade media.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Parent Company
Primary Office
- 30 Ingold Road
- Burlingame, CA 94010
- United States
+1 (650) 000-0000
Vector Laboratories Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Vector Laboratories‘s full profile, request access.
Request full access to PitchBookVector Laboratories Competitors (8)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cell Signaling Technology | Corporation | Danvers, MA | ||||
| 00000 0000 0000000 | Private Equity-Backed | Irving, TX | 000 | 00000 | 000000000 | 00000 |
| 00 000 00000000000 | Corporate Backed or Acquired | Carlsbad, CA | 00 | 000000&0 | ||
| 00000000 000000000 | Formerly VC-backed | Newark, CA | 000000&0 | |||
| 000000000 | Corporation | San Diego, CA | 000 |
Vector Laboratories Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Carl Hull | Chief Executive Officer | ||
| David Weber | Vice President & Chief Commercial Officer |
2 Former Executives
You’re viewing 2 of 4 executives. Get the full list »